Bleeding Profile With Continuous Hormone Replacement Therapy of Activelle® in Postmenopausal Women

Inclusion Criteria: * Healthy women * At least 3 months on Trisekvens® before screening period * Ability to understand and comply with the protocol requirements Exclusion Criteria: * Less than 12 months or more than 36 months postmenopausal judged by the Investigator * Known, suspected, or past history of hormone dependent tumor/cancers * Deep venous thrombosis, active thrombophlebitis, thromboembolic disorders, cerebrovascular accidents or past history of these conditions * Ischemic heart disease or myocardial infarction within 6 months prior to randomization